EARLY REASSURANCE OR FALSE SAFETY? THE FETAL HOME DOPPLER USE IN ACTIVE MONITORING IN THE FIRST TRIMESTER OF PREGNANCY - FROM THE ENDOCRINE PERSPECTIVE

早期安心还是虚假安全感?从内分泌学的角度看胎儿家庭多普勒在妊娠早期主动监测中的应用

阅读:1

Abstract

CONTEXT: The growing use of home monitoring devices during pregnancy has raised concerns about their reliability and psychological impact. From an endocrine perspective, early modulation of maternal stress through the hypothalamic-pituitary-adrenal (HPA) axis may influence fetal neuroendocrine programming. Identifying safe, reassuring tools that stabilize maternal emotional state in early gestation may support healthier endocrine adaptation for both mother and fetus. OBJECTIVE: To evaluate the feasibility and psychological effects of handheld Doppler use for fetal cardiac monitoring in early pregnancy and to explore correlations between maternal-fetal cardiac coupling and maternal anxiety. DESIGN: Prospective, observational, single-center study conducted between January 2019 and December 2023 at Polizu Clinical Hospital, Bucharest. SUBJECTS AND METHODS: One hundred women ≤14 weeks' gestation completed questionnaires evaluating handheld Doppler and pulse oximeter use. 54 received the DASS-21 anxiety subscale online; 26 provided valid responses. Comparative and correlational analyses were performed using IBM SPSS v29. RESULTS: Fetal heart rate was detected in 67% of cases, with higher detection at increasing gestational ages. Women who detected the heartbeat had higher gestational age (10.4 ± 1.8 vs. 8.6 ± 1.9 weeks, p < 0.01). Anxiety scores inversely correlated with gestational age (p = 0.019). Most participants (68%) found the Doppler reassuring. CONCLUSIONS: Handheld Doppler monitoring during early pregnancy is feasible and provides emotional reassurance, potentially stabilizing maternal stress responses and supporting maternal-fetal endocrine adaptation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。